MetaCap

Who Owns Myriad Genetics Stock?

NASDAQ: MYGNHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

5.46-0.08 (-1.44%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
95.12%
Institutional holders
253
  • Institutions 95.1%
  • Insiders 4.0%
  • Public and other 0.9%

Who owns Myriad Genetics stock?

Institutional investors own about 95.1% of Myriad Genetics's shares, spread across 253 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 4.00% of MYGN.

The largest institutional holders are Blackrock Inc. (16.60%), Millennium Management Llc (6.90%) and State Street Corporation (5.00%). Together, the top 10 institutions control 52.4% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their MYGN positions and 4 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of MYGN

Myriad Genetics top institutional holders
InstitutionShares% HeldChange
Blackrock Inc.15.92M16.60%+46.2%
Millennium Management Llc6.62M6.90%-0.7%
State Street Corporation4.80M5.00%-3.7%
Shaw D.E. & Co., Inc.4.69M4.89%+2.3%
Vanguard Capital Management LLC4.00M4.17%-1.9%
Acadian Asset Management. LLC3.46M3.61%+10.6%
Point72 Asset Management, L.P.3.23M3.37%+1251.8%
Vanguard Portfolio Management LLC2.84M2.96%-7.9%
Mackenzie Financial Corporation2.50M2.61%+62.8%
Citadel Advisors Llc2.15M2.24%+40.4%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of MYGN

Myriad Genetics top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.88M3.00%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF2.83M2.95%
iShares Trust-iShares Russell 2000 ETF2.36M2.46%
BlackRock Funds-BlackRock Advantage Small Cap Core Fund1.79M1.87%
abrdn Healthcare Opportunities Fund1.31M1.36%
TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fund1.23M1.28%
Federated Hermes MDT Series-Federated Hermes MDT Small Cap Core Fund1.12M1.16%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.11M1.16%
VANGUARD HORIZON FUNDS-Vanguard Strategic Equity Fund1.02M1.06%
iShares Trust-iShares Russell 2000 Value ETF863.77K0.90%

Frequently asked questions

Who is the largest shareholder of Myriad Genetics?

Blackrock Inc. is the largest institutional shareholder of MYGN, owning 16.60% of shares outstanding (15.92M shares) as of its latest 13F filing.

What percentage of Myriad Genetics is owned by institutions?

Institutions own about 95.1% of MYGN shares and 99.1% of the public float.

How much of Myriad Genetics do insiders own?

Insiders, such as officers and directors, own about 4.00% of MYGN shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related